Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × elacestrant × Breast × Clear all

Status

Sponsor Class

Study Type

Interventional 21 Observational 1

Sponsor

Cancer Type

Conditions

ESR1 Gene Mutation 1

Interventions

Surveys and Questionnaires 73 Blood Specimen Collection 58 palbociclib 37 Trastuzumab 32 Drug Therapy 28 Letrozole 27 Immunohistochemistry 26 Radiotherapy 25 Anastrozole 25 exemestane 20 Tamoxifen 20 Interviews as Topic 20 Fulvestrant 20 Biopsy 20 Mastectomy, Segmental 19 Amplified Fragment Length Polymorphism Analysis 19 ribociclib 18 Gene Expression Profiling 18 Magnetic Resonance Spectroscopy 17 Mastectomy 16 Specimen Handling 15 trastuzumab deruxtecan 14 Mammography 14 High-Energy Shock Waves 14 Capecitabine 14 Paclitaxel 13 Neoadjuvant Therapy 13 Psychiatric Rehabilitation 12 Observation 12 Cyclophosphamide 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06544577 2024-08-09

Safety of Elacestrant in ER+/HER2- and ESR1 Mutations MBC

SciClone Pharmaceuticals

ESR1 Gene Mutation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡